Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome.
Autor(es): Charra Boubaker; Hachimi Abdelhamid; Benslama Abdellatif; Motaouakkil Said
Resumo: The aim of the study is to compare efficacy of IvIg versus PE in treatment of mechanically ventilation adults with GBS in intensive care unit. It is a prospective, non randomized study, realized in a medical ICU from 2006 to 2010. We included all patients with GBS who required mechanical ventilation (MV). We defined two groups: group 1 (group treated by IvIg: 0.4 g/kg/day for 5 days) and group 2 (group treated by PE: 4 PE during 10-14 days). We collected demographic characteristics, clinical and therapeutic aspects and outcome. The quantitative variables are expressed on mean ± standard derivation and compared by Student test. The statistic analysis has been based on SPSS for windows. P<0.05 is considered as significant. Forty-one patients (21 in group 1 and 20 in group 2) were enrolled. The mean age was 37.4±9.2 years, with a masculine predominance (75.4%). Electromyogram in all patients found acute inflammatory demyelinating polyradiculoneuropathy in 80.5% of patients. The mean length of hospitalization was 45.3±9.2 days. The length of hospitalization of the IvIg group is less long than PE group (p=0.03). The weaning of the MV was more precocious in IvIg group than PE group (p=0.01). Also, the beginning of motility recuperation was precocious at IvIg group than PE group (p=0.04). Our work reveals a meaningful difference for the MV weaning and precocious recovery in IvIg group compared to PE group.
Palavras-Chave: Guillain Barré syndrome, intensive care unit, intravenous immunoglobulin, mechanical ventilation, plasma exchange, recovery
Imprenta: The Pan African Medical Journal, v. 18, p. 35, 2014
Identificador do objeto digital: 10.11604/pamj.2014.18.35.2911
Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Public health
Data de publicação: 2014